These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7978868)

  • 1. The noradrenaline transporter of the neuronal plasma membrane.
    Bönisch H; Brüss M
    Ann N Y Acad Sci; 1994 Sep; 733():193-202. PubMed ID: 7978868
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.
    Ramamoorthy S; Melikian HE; Qian Y; Blakely RD
    Methods Enzymol; 1998; 296():347-70. PubMed ID: 9779460
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical characterization and purification of the neuronal sodium-dependent noradrenaline transporter.
    Bönisch H; Martiny-Baron G; Blum B; Michael-Hepp J
    J Neural Transm Suppl; 1990; 32():413-9. PubMed ID: 2089105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular physiology and regulation of catecholamine transporters.
    Amara SG; Sonders MS; Zahniser NR; Povlock SL; Daniels GM
    Adv Pharmacol; 1998; 42():164-8. PubMed ID: 9327869
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular aspects of the neuronal noradrenaline transporter.
    Bönisch H; Paulus G; Martiny-Baron G; Lingen B; Coppeneur D
    J Neural Transm Suppl; 1991; 34():11-7. PubMed ID: 1726219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter.
    Lingen B; Brüss M; Bönisch H
    FEBS Lett; 1994 Apr; 342(3):235-8. PubMed ID: 8150077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A creatine transporter cDNA from Torpedo illustrates structure/function relationships in the GABA/noradrenaline transporter family.
    Guimbal C; Kilimann MW
    J Mol Biol; 1994 Aug; 241(2):317-24. PubMed ID: 8057375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport.
    Syringas M; Janin F; Mezghanni S; Giros B; Costentin J; Bonnet JJ
    Mol Pharmacol; 2000 Dec; 58(6):1404-11. PubMed ID: 11093780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of protein kinase C and second messengers in regulation of the norepinephrine transporter.
    Bönisch H; Hammermann R; Brüss M
    Adv Pharmacol; 1998; 42():183-6. PubMed ID: 9327874
    [No Abstract]   [Full Text] [Related]  

  • 11. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.
    Buck KJ; Amara SG
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12584-8. PubMed ID: 7809082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraneuronal transport of noradrenaline.
    Schömig E
    J Auton Pharmacol; 1994 Feb; 14(1):9-10. PubMed ID: 8150813
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
    Pifl C; Hornykiewicz O; Giros B; Caron MG
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
    Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
    J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
    Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
    Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake.
    Galli A; Blakely RD; DeFelice LJ
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13260-5. PubMed ID: 9789076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltammetric approaches to kinetics and mechanism of the norepinephrine transporter.
    Justice JB; Danek KS; Kable JW; Barker EL; Blakely RD
    Adv Pharmacol; 1998; 42():191-4. PubMed ID: 9327876
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular cloning and organization of the coding region of the human norepinephrine transporter gene.
    Pörzgen P; Bönisch H; Brüss M
    Biochem Biophys Res Commun; 1995 Oct; 215(3):1145-50. PubMed ID: 7488042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine transporter expression in cholinergic sympathetic neurons: differential regulation of membrane and vesicular transporters.
    Habecker BA; Klein MG; Cox BC; Packard BA
    Dev Biol; 2000 Apr; 220(1):85-96. PubMed ID: 10720433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.